Figure 3.
Altered genes in adherens junction and TGF-β pathways (PUCH and TCGA cohort), and association with prognosis. A. Oncomaps and schematics of genetic alterations in adherens junction pathway and TGF-β pathway, the frequencies (%) in PUCH cohort (yellow) and TCGA cohort (blue) are shown. B. Patients with one or more mutations in both pathways showed significantly better overall survival in PUCH cohort, and the same trend in disease-free survival data in TCGA cohort.